When it comes to point-of-care glucose testing, relying on at-home strip meters isn't enough. For lab-quality accuracy and reliable results, the CLIA-waived HemoCue® Glucose 201 System is the professional solution you need. Designed for healthcare providers, this analyzer delivers precise readings from a simple fingerstick test, making it ideal for managing patients with diabetes and identifying those at risk. Unlike traditional glucose strip meters, the HemoCue® Glucose 201 System offers the accuracy needed to support clinical decisions, including Oral Glucose Tolerance Tests (OGTT). With this system, you can confidently diagnose and treat diabetic patients, ensuring the highest standard of care in your practice.
Order Now
The HemoCue® Glucose 201 System is specifically designed to measure blood glucose levels with precision and accuracy, making it an essential tool for various clinical applications:
The system provides critical data for diagnosing diabetes, allowing healthcare professionals to monitor and manage glucose levels in patients with diabetes effectively.
The analyzer helps identify individuals at risk for diabetes by detecting elevated blood glucose levels, enabling early intervention and prevention strategies.
The HemoCue® Glucose 201 System is CLIA-waived for conducting Oral Glucose Tolerance Tests (OGTT) in-office, a key diagnostic tool for assessing how a patient’s body processes glucose.
In addition to its use in diabetes care, the system is valuable for monitoring glucose levels in patients as part of routine health checks or when there are concerns about blood sugar levels due to other medical conditions.
The HemoCue® Glucose 201 System is designed with simplicity in mind, allowing healthcare professionals to obtain precise glucose measurements quickly and efficiently. Here’s how it works:
The HemoCue® Glucose 201 System is designed to meet the demanding needs of healthcare professionals, offering a range of benefits and features that enhance its usability and reliability in clinical settings:
Principle
Modified glucose dehydrogenase in which the total amount of glucose is measured at the end point photometrically
Calibration
Factory calibrated and traceable to ID GC-MS method, needs no further calibration and no coding
Testing
Sample Material
Capillary, venous or arterial whole blood including neonatal blood
Sample Volume
Approximately 5 μL whole blood
Measuring Time
40-240 seconds
Displayed Range
Plasma equivalent values 0-444 mg/dL
Device
Dimensions
6.3x1.69x3.35 in (160x43x85 mm)
Weight
0.77 lbs. (350 g), with batteries installed
Temp Ranges
Analyzer Storage
32-122 °F (0-50 °C)
Microcuvette Storage
Below 46 °F (8 °C), incl. freezer.
Up to 3 days in room temperature.
Analyzer Operation
64-86 °F (18-30 °C)
Quality Control
Built-in self-test; system can be verified using liquid control
Power
Cable
AC Adapter
Standard Batteries
4 AA batteries 1.5 V Alkaline
Rechargable Batteries
4 AA batteries 1.2 V NiMH
Interface
Connectable to HemoCue® DMU Docking Station
CPT Codes
82947-QW 82950-QW 82951-QW 82952-QW
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
Sources: https://www.hemocue.us/glucose201/